Device Trial Radar · NCT03650244
Nationwide Observation Study to Evaluate the Efficacy and Tolerance of the Adjustable Medical Device REMEEX® in the Treatment of Male Stress Urinary Incontinence
Last checked: Nov 19, 2026Latest source record: Jun 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
100
Actual
Start
Nov 16, 2016
Primary completion
Nov 2028
Study completion Nov 2028
Sponsor
- Lead sponsor
- Centre Hospitalier Universitaire de NīmesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 28, 2018
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
We wish to set up a multicentric prospective observational study across France to collate data on the efficacy and tolerance of the Male REMEEX® device in patients with moderate stress urinary incontinence following radical prostatectomy. Patient satisfaction, improvement in quality of life, side effects and complications will also be studied, as will the ease of use of the device from the point of view of the surgeon. A long-term follow-up of 5 years will be conducted.
Conditions
- Urinary Incontinence,Stress
Interventions
REMEEX implantationDevice
Device implantation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate efficacy of REMEEX® on urinary incontinence post radical prostatectomyTime frame: 1 month
- Evaluate efficacy of REMEEX® on urinary incontinence post radical prostatectomyTime frame: 6 months
- Evaluate efficacy of REMEEX® on urinary incontinence post radical prostatectomyTime frame: 1 year
4 more outcomes with a free account
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
CHU de Besançon
Besançon, France
APHP Hôpital Henry Mondor
Créteil, France
CHU de Dijon
Dijon, France
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.